Concentric Health will exhibit at WHX Dubai as part of the UK Pavilion, spotlighting Concentric, its UK-leading digital consent-to-treatment application, and demonstrating how digital innovation can transform patient consent, shared decision-making, and clinical documentation across global healthcare systems.
Founded with a mission to make healthcare decision-making more patient-centred, informed and collaborative, Concentric Health developed its flagship application to modernise the consent-to-treatment process.
The application enables clinicians to create personalised, patient-specific consent information from an extensive evidence-based content library of more than 3,000 procedure templates. With integrated remote consent functionality, patients can review information ahead of the day of treatment, improving preparedness and reducing last-minute delays or cancellations.
Unlike paper-based consent or generic digital tools, Concentric is designed around shared decision-making. It supports meaningful conversations between clinicians and patients while fitting seamlessly into existing clinical workflows through an integration-first approach with electronic clinical systems. This ensures high-quality, standardised documentation without compromising clinician-led personalisation.
Concentric’s approach is already delivering proven results at scale. The platform is deployed across more than 40 NHS organisations, including leading institutions such as Imperial College Healthcare and Oxford University Hospitals, as well as major independent providers including Circle Health Group. Today, Concentric is used by over 15,000 clinicians each week and supports more than 2 million patients annually.
Published clinical research shows that digital consent significantly improves documentation quality and reduces errors compared to paper consent, including reductions in missing risks and completion errors. Studies also demonstrate substantial improvements in shared decision-making, with “gold-standard” shared decision-making increasing from 28% to 72%, alongside higher patient satisfaction and understanding. These improvements support safer care, fewer delays or cancellations, and reduced medicolegal risk.
Dr Patrick Hart, Growth and Partnerships Clinician at Concentric Health, said:
“Consent is not just a formality - it is a critical clinical interaction that underpins patient understanding, trust and safety. At WHX Dubai, we are excited to demonstrate how Concentric enables truly shared decision-making at scale, while supporting clinicians with high-quality, evidence-based documentation. As healthcare systems worldwide look to modernise consent, we see a significant opportunity to support safer, more patient-centred care internationally.”
At WHX Dubai, the Concentric Health team will focus on showcasing how its digital consent solution supports patient-centred care at scale. The company aims to connect with hospitals and healthcare organisations seeking to digitally transform consent processes, build relationships with clinical leaders and operational decision-makers, and explore international partnerships to support its expansion over the next 12 months.
For more information visit https://concentric.health/
